Jean-Louis Migeot argues that acoustic simulation needs to be an early part of any product design and that software is now available to ensure it can be done easily
High-performance computing is increasingly being used to interpret financial data, explains Robert Roe
John Barr looks at some of the issues surrounding the future of data centres
Reagan W Moore argues that policy-based data-management systems are the next stage in the evolution of large-scale data management
In the second part of our series on computational chemistry, Siân Harris looks at the role of modelling and high-quality data in the pharmaceutical industry
Tom Wilkie finds that this years ISC programme prompts thoughts about the relevance of railways and art 
to high-performance computing
More complex clusters mean more scope for integrators - provided they know what their customers need, as Tom Wilkie discovers
John Trigg sets out the changing demands on laboratories. Only by becoming smart can they respond effectively
The pharmaceutical industry needs new informatics tools if it is to master the age of personalised medicine, Sophia Ktori discovers
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
